C43H46F3N9O5 — CID 175629900
N-[[4-[6-[7-[3-[1-(2,6-dioxopiperidin-3-yl)-2-hydroxy-3-methyl-2H-benzimidazol-5-yl]propyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]indazol-2-yl]cyclohexyl]methyl]-2,3,5-trifluoro-4-hydroxybenzamide (PubChem CID 175629900) has the molecular formula C43H46F3N9O5 and a molecular weight of 825.89 g/mol. Its IUPAC name is N-[[4-[6-[7-[3-[1-(2,6-dioxopiperidin-3-yl)-2-hydroxy-3-methyl-2H-benzimidazol-5-yl]propyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]indazol-2-yl]cyclohexyl]methyl]-2,3,5-trifluoro-4-hydroxybenzamide.
| Compound Name | N-[[4-[6-[7-[3-[1-(2,6-dioxopiperidin-3-yl)-2-hydroxy-3-methyl-2H-benzimidazol-5-yl]propyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]indazol-2-yl]cyclohexyl]methyl]-2,3,5-trifluoro-4-hydroxybenzamide |
|---|---|
| PubChem CID | 175629900 |
| Molecular Formula | C43H46F3N9O5 |
| Molecular Weight | 825.89 g/mol |
| Exact Mass | 825.36 |
| IUPAC Name | N-[[4-[6-[7-[3-[1-(2,6-dioxopiperidin-3-yl)-2-hydroxy-3-methyl-2H-benzimidazol-5-yl]propyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]indazol-2-yl]cyclohexyl]methyl]-2,3,5-trifluoro-4-hydroxybenzamide |
| SMILES | CN1c2cc(CCCN3CCn4c(-c5ccc6cn(C7CCC(CNC(=O)c8cc(F)c(O)c(F)c8F)CC7)nc6c5)cnc4C3)ccc2N(C2CCC(=O)NC2=O)C1O |
| InChI | InChI=1S/C43H46F3N9O5/c1-51-34-17-24(6-11-32(34)55(43(51)60)33-12-13-37(56)49-42(33)59)3-2-14-52-15-16-53-35(21-47-36(53)23-52)26-7-8-27-22-54(50-31(27)18-26)28-9-4-25(5-10-28)20-48-41(58)29-19-30(44)40(57)39(46)38(29)45/h6-8,11,17-19,21-22,25,28,33,43,57,60H,2-5,9-10,12-16,20,23H2,1H3,(H,48,58)(H,49,56,59) |
| InChIKey | SJKJARLIQSSQQC-UHFFFAOYSA-N |
| XLogP | 4.97 |
| TPSA | 161.09 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 60 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 825.89 |
| LogP ≤ 5 | 4.97 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|